Neurocrine Biosciences
Clinical trials sponsored by Neurocrine Biosciences, explained in plain language.
-
New drug could slash steroid use in rare hormone disorder
Disease control OngoingThis study tests a new medicine called crinecerfont for adults with classic congenital adrenal hyperplasia (CAH), a genetic condition that disrupts hormone production. The goal is to see if the drug can safely reduce the high doses of steroids patients need to take daily. About 1…
Phase: PHASE3 • Sponsor: Neurocrine Biosciences • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New study checks safety of Huntington's chorea drug over time
Disease control ENROLLING_BY_INVITATIONThis study looks at the long-term safety of valbenazine for people with Huntington disease who have chorea (uncontrolled movements). It is for people in Canada who were in a previous valbenazine study. The main goal is to track any side effects over time.
Phase: PHASE3 • Sponsor: Neurocrine Biosciences • Aim: Disease control
Last updated May 18, 2026 12:02 UTC